Considerations For Migrating A Drug Product Presentation From Vial To Pre-Filled Syringe

By Martin Gonzalez, Ph.D., Sr. Manager Formulation and Process Development, Pfizer CentreOne


access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development

Pfizer CentreOne Sterile Injectables